Fullerton Fund Management CO Ltd. Royalty Pharma PLC Transaction History
Fullerton Fund Management CO Ltd.
- $2.74 Billion
- Q4 2024
A detailed history of Fullerton Fund Management CO Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fullerton Fund Management CO Ltd. holds 15,205 shares of RPRX stock, worth $509,367. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,205
Previous 15,205
-0.0%
Holding current value
$509,367
Previous $430,000
10.0%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
434Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$771 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$568 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$474 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...